Finding 575108 (2024-105)

Material Weakness Repeat Finding
Requirement
ABH
Questioned Costs
-
Year
2024
Accepted
2025-08-28
Audit: 365222
Organization: Pancare of Florida, INC (FL)

AI Summary

  • Core Issue: Lack of formal documentation for employee time approval by supervisors, leading to a material weakness in internal controls over payroll.
  • Impacted Requirements: Compliance with 2 CFR section 200.303, which mandates effective internal controls for managing federal awards.
  • Recommended Follow-up: Ensure the new payroll process with ADP is fully implemented, maintaining documentation of supervisor approvals and regular reviews to prevent errors.

Finding Text

2024-105 Lack of Payroll Review and Approval (repeated, prior year 2023-105) (initially reported 2023) Assistance Listing Number: 93.224, 93.527 and 93.211 Name of Federal Agency: Department of Health and Human Services, HRSA Program Title: Health Center Program (Community Health Centers, Migrant Health Centers, Health Care for the Homeless, and Public Housing Primary Care) and Grants for New and Expanded Services Under the Health Center Program and Rural Telemedicine Grants Compliance Requirement: Allowable Activities and Allowable Costs, Period of Performance Pass-through Entity: N/A Federal Grant/Contract Number and Grant Year: H8006452 (2024 and 2023), H2E45500 (2022), H8K49674 (2023), COVID-19 H2E50094 (2023), H8N53812 (2024), H8L50549 (2023), COVID-19 H8G48569 (2022), GA142923 (2021), G2846293(2022) and G3949501 (2023) Finding Type: Material Weakness in Internal Control Questioned Costs: $0 Condition: No documentation of employee time approval by supervisors could be provided. The payroll clerk processes the payroll, and the finance director approves through the releasing of the payroll. However, there is no formal documentation of the overall review of the payroll process and the supervisors’ approval of time recorded by employees. This is a systemic issue and has been a finding in the previous year. Criteria: 2 CFR section 200.303 requires that nonfederal entities receiving federal awards establish and maintain internal control over the federal awards that provides reasonable assurance that the nonfederal entity is managing the federal awards in compliance with federal statutes, regulations, and the terms and conditions of the federal awards The requirement is for the Organization to have a process in place to correctly calculate, record, and pay payroll related expenses in accordance with grant and program requirements. Cause: The Organization does not have an effective process to review, approve, and document the supervisor’s approvals prior to making the payments. Effect: This situation provides an opportunity for errors and unauthorized transactions to occur and not be detected in a timely manner resulting in payroll expenses to be charged incorrectly to the federal awards. Recommendation: In April 2024, the Organization began using a third-party service provider to process payroll resulting in new control processes over the approval of time sheets by supervisors. We recommend that the Organization implement internal control procedures under the new payroll processes to ensure that documentation of supervisor approval of time sheets and subsequent payments is kept on file. Views of Responsible Officials and Planned Corrective Actions: The Organization has implemented a new payroll process using the ADP system. Employees are now required to approve their own time within the ADP portal, and this approval is documented. Following this, supervisors review and approve their employees’ time, which is also documented in the portal. Human Resources then prepares the payroll, reviewing all entries and initialing a shared file of payroll items and providing backup for changes. Once HR confirms accuracy, they notify Finance. Finance then reviews the payroll, with the Finance Manager providing the final approval within ADP once all items are confirmed. This entire process is fully documented, with approvals recorded within ADP by employees and supervisors and the shared file drive where HR and Finance initial off on the reviewed payroll items, ensuring a traceable record of the entire payroll approval process.

Categories

Subrecipient Monitoring Allowable Costs / Cost Principles HUD Housing Programs Material Weakness Period of Performance Matching / Level of Effort / Earmarking Internal Control / Segregation of Duties

Other Findings in this Audit

  • 575077 2024-101
    Material Weakness Repeat
  • 575078 2024-104
    Significant Deficiency Repeat
  • 575079 2024-105
    Material Weakness Repeat
  • 575080 2024-106
    Material Weakness
  • 575081 2024-101
    Material Weakness Repeat
  • 575082 2024-104
    Significant Deficiency Repeat
  • 575083 2024-105
    Material Weakness Repeat
  • 575084 2024-106
    Material Weakness
  • 575085 2024-101
    Material Weakness Repeat
  • 575086 2024-104
    Significant Deficiency Repeat
  • 575087 2024-105
    Material Weakness Repeat
  • 575088 2024-106
    Material Weakness
  • 575089 2024-101
    Material Weakness Repeat
  • 575090 2024-104
    Significant Deficiency Repeat
  • 575091 2024-105
    Material Weakness Repeat
  • 575092 2024-106
    Material Weakness
  • 575093 2024-101
    Material Weakness Repeat
  • 575094 2024-104
    Significant Deficiency Repeat
  • 575095 2024-105
    Material Weakness Repeat
  • 575096 2024-106
    Material Weakness
  • 575097 2024-104
    Significant Deficiency Repeat
  • 575098 2024-101
    Material Weakness Repeat
  • 575099 2024-104
    Significant Deficiency Repeat
  • 575100 2024-105
    Material Weakness Repeat
  • 575101 2024-106
    Material Weakness
  • 575102 2024-101
    Material Weakness Repeat
  • 575103 2024-104
    Significant Deficiency Repeat
  • 575104 2024-105
    Material Weakness Repeat
  • 575105 2024-106
    Material Weakness
  • 575106 2024-101
    Material Weakness Repeat
  • 575107 2024-104
    Significant Deficiency Repeat
  • 575109 2024-106
    Material Weakness
  • 575110 2024-102
    Significant Deficiency
  • 575111 2024-104
    Significant Deficiency Repeat
  • 575112 2024-105
    Material Weakness Repeat
  • 575113 2024-106
    Material Weakness
  • 575114 2024-107
    Significant Deficiency
  • 575115 2024-102
    Significant Deficiency
  • 575116 2024-104
    Significant Deficiency Repeat
  • 575117 2024-105
    Material Weakness Repeat
  • 575118 2024-106
    Material Weakness
  • 575119 2024-107
    Significant Deficiency
  • 575120 2024-104
    Significant Deficiency Repeat
  • 575121 2024-105
    Material Weakness Repeat
  • 575122 2024-106
    Material Weakness
  • 575123 2024-107
    Significant Deficiency
  • 1151519 2024-101
    Material Weakness Repeat
  • 1151520 2024-104
    Significant Deficiency Repeat
  • 1151521 2024-105
    Material Weakness Repeat
  • 1151522 2024-106
    Material Weakness
  • 1151523 2024-101
    Material Weakness Repeat
  • 1151524 2024-104
    Significant Deficiency Repeat
  • 1151525 2024-105
    Material Weakness Repeat
  • 1151526 2024-106
    Material Weakness
  • 1151527 2024-101
    Material Weakness Repeat
  • 1151528 2024-104
    Significant Deficiency Repeat
  • 1151529 2024-105
    Material Weakness Repeat
  • 1151530 2024-106
    Material Weakness
  • 1151531 2024-101
    Material Weakness Repeat
  • 1151532 2024-104
    Significant Deficiency Repeat
  • 1151533 2024-105
    Material Weakness Repeat
  • 1151534 2024-106
    Material Weakness
  • 1151535 2024-101
    Material Weakness Repeat
  • 1151536 2024-104
    Significant Deficiency Repeat
  • 1151537 2024-105
    Material Weakness Repeat
  • 1151538 2024-106
    Material Weakness
  • 1151539 2024-104
    Significant Deficiency Repeat
  • 1151540 2024-101
    Material Weakness Repeat
  • 1151541 2024-104
    Significant Deficiency Repeat
  • 1151542 2024-105
    Material Weakness Repeat
  • 1151543 2024-106
    Material Weakness
  • 1151544 2024-101
    Material Weakness Repeat
  • 1151545 2024-104
    Significant Deficiency Repeat
  • 1151546 2024-105
    Material Weakness Repeat
  • 1151547 2024-106
    Material Weakness
  • 1151548 2024-101
    Material Weakness Repeat
  • 1151549 2024-104
    Significant Deficiency Repeat
  • 1151550 2024-105
    Material Weakness Repeat
  • 1151551 2024-106
    Material Weakness
  • 1151552 2024-102
    Significant Deficiency
  • 1151553 2024-104
    Significant Deficiency Repeat
  • 1151554 2024-105
    Material Weakness Repeat
  • 1151555 2024-106
    Material Weakness
  • 1151556 2024-107
    Significant Deficiency
  • 1151557 2024-102
    Significant Deficiency
  • 1151558 2024-104
    Significant Deficiency Repeat
  • 1151559 2024-105
    Material Weakness Repeat
  • 1151560 2024-106
    Material Weakness
  • 1151561 2024-107
    Significant Deficiency
  • 1151562 2024-104
    Significant Deficiency Repeat
  • 1151563 2024-105
    Material Weakness Repeat
  • 1151564 2024-106
    Material Weakness
  • 1151565 2024-107
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
93.526 Covid-19 Grants for Capital Development in Health Centers $728,277
10.766 Community Facilities Loans and Grants $411,641
93.224 Covid-19 Health Center Program (community Health Centers, Migrant Health Centers, Health Care for the Homeless, and Public Housing Primary Care) $346,967
93.211 Telehealth Programs $309,134
93.918 Grants to Provide Outpatient Early Intervention Services with Respect to Hiv Disease $275,916
93.224 Health Center Program (community Health Centers, Migrant Health Centers, Health Care for the Homeless, and Public Housing Primary Care) $175,931
93.939 Hiv Prevention Activities Non-Governmental Organization Based $149,480
93.527 Grants for New and Expanded Services Under the Health Center Program $121,766
93.243 Substance Abuse and Mental Health Services Projects of Regional and National Significance $103,014
10.855 Distance Learning and Telemedicine Loans and Grants $59,029
93.969 Pphf Geriatric Education Centers $33,933
93.527 Covid-19 Grants for New and Expanded Services Under the Health Center Program $27,500